Cell therapy against cancer

Ryuji Tanosaki, Y. Takaue

Research output: Contribution to journalReview article

Abstract

Because of the recent advances in immunology, the development of cell processing techniques, and the discovery of tumor-associated antigens, etc., many clinical trials on cell therapy using specific tumor-associated molecules against cancer are now being conducted throughout the world. In particular, dendritic cells, the most potent antigen-presenting cells in the immune system, are being vigorously investigated. On the other hand, lines of evidence have revealed that allogeneic hematopoietic stem cell transplantation can also serve as a potent immunotherapy. In order to establish the status of cell therapy as the 4th treatment against cancer, the infrastructure for this treatment should be reviewed, on the basis of which well-defined clinical trials should be performed, and the evidence of clinical efficacy accumulated.

Original languageEnglish
Pages (from-to)621-629
Number of pages9
JournalBiotherapy
Volume15
Issue number6
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Cell- and Tissue-Based Therapy
Clinical Trials
Neoplasms
Hematopoietic Stem Cell Transplantation
Neoplasm Antigens
Antigen-Presenting Cells
Allergy and Immunology
Immunotherapy
Dendritic Cells
Immune System
Therapeutics

Keywords

  • Cell therapy
  • Dendritic cell
  • Non-myeloablative transplantation
  • Tumor vaccine

ASJC Scopus subject areas

  • Cancer Research
  • Immunology and Allergy

Cite this

Tanosaki, R., & Takaue, Y. (2001). Cell therapy against cancer. Biotherapy, 15(6), 621-629.

Cell therapy against cancer. / Tanosaki, Ryuji; Takaue, Y.

In: Biotherapy, Vol. 15, No. 6, 2001, p. 621-629.

Research output: Contribution to journalReview article

Tanosaki, R & Takaue, Y 2001, 'Cell therapy against cancer', Biotherapy, vol. 15, no. 6, pp. 621-629.
Tanosaki R, Takaue Y. Cell therapy against cancer. Biotherapy. 2001;15(6):621-629.
Tanosaki, Ryuji ; Takaue, Y. / Cell therapy against cancer. In: Biotherapy. 2001 ; Vol. 15, No. 6. pp. 621-629.
@article{8c825d2ca0f84789a34bbd872c059df5,
title = "Cell therapy against cancer",
abstract = "Because of the recent advances in immunology, the development of cell processing techniques, and the discovery of tumor-associated antigens, etc., many clinical trials on cell therapy using specific tumor-associated molecules against cancer are now being conducted throughout the world. In particular, dendritic cells, the most potent antigen-presenting cells in the immune system, are being vigorously investigated. On the other hand, lines of evidence have revealed that allogeneic hematopoietic stem cell transplantation can also serve as a potent immunotherapy. In order to establish the status of cell therapy as the 4th treatment against cancer, the infrastructure for this treatment should be reviewed, on the basis of which well-defined clinical trials should be performed, and the evidence of clinical efficacy accumulated.",
keywords = "Cell therapy, Dendritic cell, Non-myeloablative transplantation, Tumor vaccine",
author = "Ryuji Tanosaki and Y. Takaue",
year = "2001",
language = "English",
volume = "15",
pages = "621--629",
journal = "Biotherapy",
issn = "0914-2223",
publisher = "Japanese Society for Cancer Chemotherapy",
number = "6",

}

TY - JOUR

T1 - Cell therapy against cancer

AU - Tanosaki, Ryuji

AU - Takaue, Y.

PY - 2001

Y1 - 2001

N2 - Because of the recent advances in immunology, the development of cell processing techniques, and the discovery of tumor-associated antigens, etc., many clinical trials on cell therapy using specific tumor-associated molecules against cancer are now being conducted throughout the world. In particular, dendritic cells, the most potent antigen-presenting cells in the immune system, are being vigorously investigated. On the other hand, lines of evidence have revealed that allogeneic hematopoietic stem cell transplantation can also serve as a potent immunotherapy. In order to establish the status of cell therapy as the 4th treatment against cancer, the infrastructure for this treatment should be reviewed, on the basis of which well-defined clinical trials should be performed, and the evidence of clinical efficacy accumulated.

AB - Because of the recent advances in immunology, the development of cell processing techniques, and the discovery of tumor-associated antigens, etc., many clinical trials on cell therapy using specific tumor-associated molecules against cancer are now being conducted throughout the world. In particular, dendritic cells, the most potent antigen-presenting cells in the immune system, are being vigorously investigated. On the other hand, lines of evidence have revealed that allogeneic hematopoietic stem cell transplantation can also serve as a potent immunotherapy. In order to establish the status of cell therapy as the 4th treatment against cancer, the infrastructure for this treatment should be reviewed, on the basis of which well-defined clinical trials should be performed, and the evidence of clinical efficacy accumulated.

KW - Cell therapy

KW - Dendritic cell

KW - Non-myeloablative transplantation

KW - Tumor vaccine

UR - http://www.scopus.com/inward/record.url?scp=0035664672&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035664672&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:0035664672

VL - 15

SP - 621

EP - 629

JO - Biotherapy

JF - Biotherapy

SN - 0914-2223

IS - 6

ER -